DBV Technologies is a startup based in France, most recent round Series-c-plus, 3 tracked investors.
DBV Technologies is a startup based in France. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
DBV Technologies is a clinical-stage biopharmaceutical company focused on developing non-invasive immunotherapy treatments for food allergies using its proprietary Viaskin patch technology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.